Sophia Genetics which is believed to be one of the biggest leaders in data-driven medicine, made an announcement today that their new CMO and CIO are Gaëtan Fraikin and Sergei Yankees. They have will bring highly specialized experience for decades of from key players in the health tech industry.
Jurgi Camblong, CEO and co-founder of Sophia Genetic affirmed that their arrival has shown continued efforts to democratize data-driven medicine globally. They both share their vision and perfectly understand the next opportunities they will help achieve. Also, Gaëtan Fraikin brings unmatched experience building and launching diagnostic and medical device brands.
Gaetan Fraikin has worked with hundreds of clients including Illumina, 23andMe, Grail, Genentech, Merck, Amgen, Invitae, Quest Diagnostics, and LabCorp while driving his branding and advertising agency Audacity. More recently, he led global marketing and branding at Illumina and Roche Sequencing, where he successfully helped launch flagship products NovaSeq and Harmony NIPT.
Franklin, when asked about the company and what the future holds for the company according to him, said that Sophia Genetics is building the future of diagnostics and healthcare in cancer and rare diseases. They rely on pulling data from multiple sources, starting with genomics, adding radionics and others in the future, to build multi-dimensional models of disease. He further added that the company holds the power of global collaboration through its fast-growing network of 1,000+ partners. He said he is thrilled to be a part of this journey which helps in accelerating the realization of this vision and impacts the lives of millions worldwide.
Proving himself as an accomplished scientific researcher, Dr. Sergei Yakneen has the technical working group of the world’s largest international cancer genome analysis project, the Pan-Cancer Analysis of Whole Genomes. He has also devised the newly distributed computing methods for data analysis of genomics.